PROS1 and glioblastoma: Because glioblastoma is proven to be driven by epigenetic alteration, including mRNA manipulating the expression of oncogenes, targeting m6A regulatory proteins can serve as a new approach for precisely modifying the epitranscriptome of glioblastoma and lead to a more personalized approach to glioblastoma treatment.